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Improving the Value of Transcather Aortic Valve Replacement (TAVR)
Braden W. Batkoffa, Ty J Gluckmanb, Robert F. Huntera, Michael Ringa, Leland Siweka, Branden Reynoldsa, Matthew Forrestera, Steven Thewc
aProvidence Spokane Heart Institute, Providence St. Joseph Health, Spokane, WA; b Center for Cardiovascular Analytics, Research and Data Science (CARDS), Providence St. Joseph Heart Institute, Portland, Oregon;    
c Kootenai Heart Clinics Northwest, Kootenai, Idaho
• Transcatheter aortic valve replacement (TAVR) represents a transformational technology for patients with severe
symptomatic aortic stenosis.
• The cost of performing this procedure, however, can be prohibitive, which can impact an organization’s ability to
meet growing clinical need.
Background
• In an attempt to lower the direct hospital costs of TAVR, and increase capacity for growing clinical need, a
multidisciplinary team from our health system was convened in 2016 to review the absolute and relative
contributions to the procedure’s direct costs.
• Team members from interventional cardiology, cardiothoracic surgery, anesthesia, the operating room, and recovery
room sought to standardize multiple aspects of the procedure’s workflow.
• Each step in the care delivery process was mapped, with elimination of steps that provided little to no value..
Methods
• Application of lean methodology and process mapping in TAVR resulted in reduced cost and improved quality for 
patients undergoing this procedure..
Conclusions
Results
Disclosures for Brad Batkoff, MD: None: 
• Partly from workflow standardization and partly from modifying existing protocols to match the increased 
treatment of intermediate risk patients, 
• mean case time was reduced by 30 minutes (18%), 
• length of stay was reduced by 2.18 days (44%),
• direct hospital costs were reduced by $7,800 (16%).  
• Operating room capacity increased from 2 cases/day to 4 cases/day, as total case volume grew by 70%.  
• Unadjusted, in-hospital mortality over 12 months decreased from 3.4% in 2015 to 0.6% 
• Average net income per case improved from a loss of $2,000 in 2015 to a gain of $12,000 in 2017. 
• Case mix index decreased from 8.12 to 7.48 during this same time frame.  
• The most notable operational improvements included greater use of moderate conscious sedation (versus general 
anesthesia), reduced use of intensive care unit services, and increased percutaneous access.
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